Pharmacokinetics, pharmacodynamics, and safety of exenatide in patients with type 2 diabetes mellitus

1998, Lancet, 352, 837, 10.1016/S0140-6736(98)07019-6

1995, Diabetes, 44, 1249, 10.2337/diab.44.11.1249

2002, Diabetes Care, 25, S28, 10.2337/diacare.25.2007.S28

1999, Diabetes Care, 22, 403, 10.2337/diacare.22.3.403

2002, JAMA, 287, 360, 10.1001/jama.287.3.360

1999, Ann Intern Med, 131, 281, 10.7326/0003-4819-131-4-199908170-00008

1992, J Biol Chem, 267, 7402, 10.1016/S0021-9258(18)42531-8

2002

1997, J Biol Chem, 272, 4108, 10.1074/jbc.272.7.4108

1999, Diabetes, 48, 1026, 10.2337/diabetes.48.5.1026

2002, J Clin Endocrinol Metab, 87, 1282, 10.1210/jcem.87.3.8337

2001, Metabolism, 50, 583, 10.1053/meta.2001.22519

2000, Endocrinology, 141, 1936, 10.1210/endo.141.6.7490

2003, Curr Opin Investig Drugs, 4, 401

1999, Diabetes, 48, 2270, 10.2337/diabetes.48.12.2270

2002, Diabetes, 51, 1443, 10.2337/diabetes.51.5.1443

2001, Diabetes, 50, 1562, 10.2337/diabetes.50.7.1562

2001, Diabetes Care, 24, 371, 10.2337/diacare.24.2.371

1999, Diabetologia, 42, 45, 10.1007/s001250051111

1993, J Biol Chem, 268, 19650, 10.1016/S0021-9258(19)36565-2

1997, JAMA, 277, 925, 10.1001/jama.1997.03540350075038

1978, Clin Pharmacol Ther, 24, 420, 10.1002/cpt1978244420

2003, Diabetes Care, 26, 2370, 10.2337/diacare.26.8.2370

2003, J Biopharm Stat, 13, 179, 10.1081/BIP-120019265

2001, Drug Dev Res, 53, 260, 10.1002/ddr.1195

1995, Endocrinology, 136, 3585, 10.1210/endo.136.8.7628397

1995, Diabetes, 44, 1126, 10.2337/diab.44.9.1126

2003, J Clin Endocrinol Metab, 88, 3082, 10.1210/jc.2002-021545

2000, Diabetes, 49, 1751, 10.2337/diabetes.49.11.1751

1999, J Clin Endocrinol Metab, 84, 1165, 10.1210/jcem.84.4.5612

1996, Reprod Nutr Dev, 36, 399, 10.1051/rnd:19960406

1996, Diabet Med, 13, S34, 10.1002/dme.1996.13.s1.34

1997, Diabetologia, 40, 136, 10.1007/s001250050654

1987, Surg Gynecol Obstet, 165, 41

1976, Gastroenterology, 70, 190, 10.1016/S0016-5085(76)80008-X